Reglan: Effective Relief for Gastroparesis and Severe Heartburn
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.46 | $41.17 (0%) | 🛒 Add to cart |
| 120 | $0.43 | $54.89 $51.21 (7%) | 🛒 Add to cart |
| 180 | $0.40 | $82.34 $71.29 (13%) | 🛒 Add to cart |
| 270 | $0.38 | $123.51 $102.42 (17%) | 🛒 Add to cart |
| 360 | $0.37
Best per pill | $164.68 $132.55 (20%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Reglan (metoclopramide hydrochloride) is a prescription medication designed to accelerate gastric emptying and enhance upper gastrointestinal motility. It is primarily indicated for the short-term treatment of adults with diabetic gastroparesis and for the relief of heartburn associated with gastroesophageal reflux when conventional therapies have proven inadequate. By facilitating the movement of food through the stomach and intestines, Reglan helps alleviate distressing symptoms such as nausea, vomiting, persistent fullness, and acid reflux. Its prokinetic and antiemetic properties make it a valuable therapeutic option in managing specific gastrointestinal dysfunctions under careful medical supervision.
Features
- Active ingredient: Metoclopramide hydrochloride
- Available in 5 mg and 10 mg oral tablets
- Also supplied as an injectable solution for hospital use
- Rapid onset of action, typically within 30–60 minutes orally
- FDA-approved for specific gastrointestinal indications
- Requires prescription and medical oversight
Benefits
- Accelerates gastric emptying, reducing discomfort from delayed digestion
- Effectively relieves nausea and vomiting associated with gastroparesis
- Decreases symptoms of severe, refractory heartburn and acid reflux
- Helps improve glycemic control in diabetic patients by stabilizing food absorption
- Provides an alternative when first-line gastroesophageal reflux treatments fail
- Available in multiple formulations for flexible administration
Common use
Reglan is commonly prescribed for the short-term treatment (typically 4 to 12 weeks) of diabetic gastroparesis, a condition where the stomach empties too slowly, causing bloating, nausea, and vomiting. It is also used to manage severe gastroesophageal reflux disease (GERD) that has not responded adequately to other medications like proton pump inhibitors or H2 blockers. In clinical settings, the injectable form may be used postoperatively to prevent nausea and vomiting or to facilitate small bowel intubation. Off-label uses sometimes include chemotherapy-induced nausea and vomiting, though this is not an FDA-approved indication.
Dosage and direction
For adults with diabetic gastroparesis, the usual oral dosage is 10 mg taken 30 minutes before each meal and at bedtime. Treatment should not exceed 12 weeks due to the risk of tardive dyskinesia. For GERD, the dose is typically 10 to 15 mg up to four times daily before meals and at bedtime. The injectable form is administered intramuscularly or intravenously under medical supervision, with dosages adjusted based on clinical need and patient response. Dosage should be reduced in patients with renal impairment or hepatic insufficiency. Always follow the specific instructions provided by the prescribing physician.
Precautions
Patients should use Reglan with caution due to the potential for serious neurological effects. It should not be used for longer than 12 weeks. Elderly patients and those with Parkinson’s disease are at increased risk for extrapyramidal symptoms. Use during pregnancy only if clearly needed, as safety has not been fully established. Metoclopramide is excreted in breast milk; caution is advised during lactation. Patients should avoid activities requiring mental alertness, such as driving, until they know how the medication affects them, as drowsiness or dizziness may occur.
Contraindications
Reglan is contraindicated in patients with known hypersensitivity to metoclopramide or any component of the formulation. It should not be used in patients with gastrointestinal obstruction, perforation, or hemorrhage. Use is also contraindicated in patients with pheochromocytoma due to the risk of hypertensive crisis, and in those with epilepsy or receiving other drugs that may cause extrapyramidal reactions. Concomitant use with drugs that prolong the QT interval is not recommended.
Possible side effect
Common side effects include restlessness, drowsiness, fatigue, and headache. More serious adverse effects may include tardive dyskinesia (involuntary, repetitive body movements), which can be irreversible, neuroleptic malignant syndrome, depression, and Parkinsonian symptoms. Other potential reactions include diarrhea, nausea, and changes in blood pressure or heart rate. Any signs of involuntary movements, especially of the face or tongue, should be reported to a healthcare provider immediately.
Drug interaction
Reglan may interact with central nervous system depressants such as alcohol, sedatives, and opioids, potentiating drowsiness. It can affect the absorption of other drugs by altering gastrointestinal motility. Concurrent use with dopaminergic antagonists or antipsychotics may increase the risk of extrapyramidal symptoms. Caution is advised when using with serotonergic drugs due to the potential for serotonin syndrome. It may also interfere with the efficacy of levodopa and other Parkinson’s medications.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is nearly time for the next dose. In that case, skip the missed dose and resume the regular schedule. Do not double the dose to make up for a missed one. Consistent timing relative to meals is important for optimal effect.
Overdose
Symptoms of overdose may include drowsiness, disorientation, extrapyramidal reactions, and cardiovascular irregularities. In case of suspected overdose, seek immediate medical attention. Treatment is supportive and may include administration of anticholinergic or antiparkinsonian agents for neurological symptoms. There is no specific antidote for metoclopramide overdose.
Storage
Store at room temperature (20–25°C or 68–77°F), away from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. For the injectable form, follow specific storage instructions provided with the product.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and patient reports indicate that Reglan can be highly effective for its approved uses, with many patients experiencing significant relief from gastroparesis and refractory GERD symptoms. However, reviews often highlight concerns about side effects, particularly the risk of tardive dyskinesia with prolonged use. Most healthcare providers emphasize short-term use under close supervision to balance benefits and risks. Patient experiences vary, with some noting substantial improvement in quality of life, while others discontinue due to adverse effects.